Glaxo has sent letters to lawyers advertising for cases over the Avandia diabetes drug, demanding that they pull what the company contends are false or misleading ads.
``Lawyers have a right to advertise, but they have to play by the rules just like we do,'' Chris Viehbacher, president of Glaxo's U.S. unit, said - according to a Bloomberg.com post. It's worth your reading.
